Barbara Gayle Duncan - Director at Halozyme Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
HALO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Barbara Gayle Duncan since 12/22/2023

Holdings reported by Barbara Gayle Duncan for Halozyme Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 15.8K $606K $38.49 Apr 25, 2024 Direct
Option to Purchase Common Stock 8.8K $122K $13.87 Apr 25, 2024 Direct Common Stock

Transactions reported by Barbara Gayle Duncan for Halozyme Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.